Published on
March 12, 2018
- 12:00 GMT
Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura
Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (“CFA”) Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (“CNA”) Further development of Sollpura to be discontinued Anthera to evaluate all …
Distribution channels:
Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry
...
